.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Citi
US Army
Express Scripts
QuintilesIMS
Johnson and Johnson
Teva
Farmers Insurance
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,590,213

« Back to Dashboard

Claims for Patent: 4,590,213

Title: Anti-anxiety method
Abstract:This invention provides for a method of treating anxiety which comprises the administration of fluoxetine or norfluoxetine or pharmaceutically aceptable salts thereof.
Inventor(s): Stark; Paul (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:06/483,087
Patent Claims: 1. A method for treating anxiety in a human subject in need of such treatment which comprises the administration to said human of an effective amount of fluoxetine or norfluoxetine or pharmaceutically acceptable salts thereof.

2. A method according to claim 1 wherein the compound is fluoxetine or a pharmaceutically acceptable salt thereof.

3. A method according to claim 2 in which the compound is administered orally.

4. A method according to claim 3 in which fluoxetine is administered as the hydrochloride salt.

5. A method according to claim 4 in which the daily dosage level is 20-80 mg.

6. A method according to claim 5 in which the daily dosage level is 60-80 mg.

7. A method according to claim 1 wherein the compound is norfluoxetine or a pharmaceutically acceptable salt thereof.

8. A method according to claim 7 in which the compound is administered orally.

9. A method according to claim 8 in which norfluoxetine is administered as the hydrochloride salt.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Mallinckrodt
Healthtrust
Deloitte
AstraZeneca
Medtronic
Colorcon
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot